ESTABLISHMENT OF THE HUMAN BSMZ BREAST-CANCER CELL-LINE, WHICH OVEREXPRESSES THE ERBB-2 AND C-MYC GENES

被引:0
|
作者
WATANABE, M
TANAKA, H
KAMADA, M
OKANO, JH
TAKAHASHI, H
UCHIDA, K
IWAMURA, A
ZENIYA, M
OHNO, T
机构
[1] JIKEI UNIV,DEPT MICROBIOL,3-25-8 NISHISHINBASHI,MINATO KU,TOKYO 105,JAPAN
[2] JIKEI UNIV,DEPT INTERNAL MED,TOKYO 105,JAPAN
[3] JIKEI UNIV,INST MED,TOKYO 105,JAPAN
[4] JIKEI UNIV,DEPT RADIOL,TOKYO 105,JAPAN
[5] JIKEI UNIV,DEPT SURG,TOKYO 105,JAPAN
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A new cell line, designated BSMZ, was established from a malignant pleural effusion from a woman with breast cancer. This line has a doubling time of 27 h and has now been cultured for over 120 passages. The large, rounded BSMZ cells grow as both a monolayer and as aggregations in suspension. Intracytoplasmic lumen, a finding consistent with results from cells derived from mammary tissue, was detected on ultrastructural analysis. Injection of BSMZ cells into nude mice resulted in the growth of solid tumors 4 weeks after inoculation. The solid tumor was identical to the original BSMZ cells in microscopic and electron microscopic studies. These cells possess an average of 80 chromosomes. Expression of erbB-2 and c-myc genes was increased by 10-fold, while there was no detectable overexpression of the N-ras and c-myb genes. Southern analysis has revealed amplification of the erbB-2 and c-myc loci. The BSMZ cell line may therefore provide a useful model for the study of human breast cancer and overexpression of the erbB-2 gene.
引用
收藏
页码:5178 / 5182
页数:5
相关论文
共 50 条
  • [1] C-ERBB2 AND C-MYC GENES AND THEIR EXPRESSION IN NORMAL-TISSUES AND IN HUMAN BREAST-CANCER
    GULLICK, WJ
    TUZI, NL
    KUMAR, S
    PATERSON, H
    QUIRKE, P
    VENTER, DJ
    MOLECULAR DIAGNOSTICS OF HUMAN CANCER, 1989, 7 : 393 - 398
  • [2] ERBB-2 AND MYC ONCOPROTEINS IN SERA AND TUMORS OF BREAST-CANCER PATIENTS
    BREUER, B
    DEVIVO, I
    LUO, JC
    SMITH, S
    PINCUS, MR
    TATUM, AH
    DAUCHER, J
    MINICK, CR
    MILLER, DG
    NOWAK, EJ
    CODY, HS
    NIMAN, H
    CARNEY, WP
    BRANDTRAUF, PW
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1994, 3 (01) : 63 - 66
  • [3] ESTABLISHMENT OF A HUMAN-MALIGNANT MENINGIOMA CELL-LINE WITH AMPLIFIED C-MYC ONCOGENE
    TANAKA, K
    SATO, C
    MAEDA, Y
    KOIKE, M
    MATSUTANI, M
    YAMADA, K
    MIYAKI, M
    CANCER, 1989, 64 (11) : 2243 - 2249
  • [4] ACTIVATION OF ERBB-2 ONCOGENE AND PROGNOSIS IN HUMAN BREAST-CANCER
    IMYANITOV, YN
    KNYAZEV, PG
    VOPROSY ONKOLOGII, 1991, 37 (05) : 527 - 534
  • [5] ALTERATIONS IN COPY NUMBER OF C-ERBB-2 AND C-MYC PROTOONCOGENES IN ADVANCED STAGE OF HUMAN BREAST-CANCER
    TSUDA, H
    HIROHASHI, S
    HIROTA, T
    SHIMOSATO, Y
    ACTA PATHOLOGICA JAPONICA, 1991, 41 (01): : 19 - 23
  • [6] C-MYC AMPLIFICATION CORRELATES WITH TUMORIGENICITY IN A HUMAN-BREAST CARCINOMA CELL-LINE
    BRISON, O
    MODJTAHEDI, N
    LAVIALLE, C
    POUPON, MF
    LANDIN, RM
    CASSINGENA, R
    MONIER, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 70 - 70
  • [7] AMPLIFICATION OF C-MYC BUT NOT OF C-ERBB-2 IS ASSOCIATED WITH HIGH PROLIFERATIVE CAPACITY IN BREAST-CANCER
    KREIPE, H
    FEIST, H
    FISCHER, L
    FELGNER, J
    HEIDORN, K
    METTLER, L
    PARWARESCH, R
    CANCER RESEARCH, 1993, 53 (08) : 1956 - 1961
  • [8] DECREASE OF C-ERBB-2 AND C-MYC RNA LEVELS IN TAMOXIFEN-TREATED BREAST-CANCER
    LEROY, X
    ESCOT, C
    BROUILLET, JP
    THEILLET, C
    MAUDELONDE, T
    SIMONYLAFONTAINE, J
    PUJOL, H
    ROCHEFORT, H
    ONCOGENE, 1991, 6 (03) : 431 - 437
  • [9] INTERFERON INDUCED INCREASES IN C-MYC EXPRESSION IN A HUMAN BREAST-CARCINOMA CELL-LINE
    HAMBURGER, AW
    PINNAMANENI, G
    ANTICANCER RESEARCH, 1991, 11 (05) : 1891 - 1894
  • [10] DISTINCT RESPONSES OF PROTEIN-KINASE-C ISOZYMES TO C-ERBB-2 ACTIVATION IN BREAST-CANCER CELL-LINE
    DISATNIK, MH
    ARTEAGA, C
    MOCHLYROSEN, D
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 74 - 74